Clinical trial / 2008
A 4-year soy protein diet improved lipid levels, fasting glucose, CRP, and kidney biomarkers in type 2 diabetic patients with nephropathy.
Forty-one type 2 diabetic patients with nephropathy were randomized to consume a diet containing either 35% animal protein, 35% textured soy protein, and 30% vegetable protein (n=20) or 70% animal protein and 30% vegetable protein (n=21) for 4 years. Compared to controls, soy protein significantly reduced fasting plasma glucose (-18 +/- 3 vs. 11 +/- 2 mg/dl; P = 0.03), total cholesterol (-23 +/- 5 vs. 10 +/- 3 mg/dl; P = 0.01), LDL cholesterol (-20 +/- 5 vs. 6 +/- 2 mg/dl; P = 0.01), and triglycerides (-24 +/- 6 vs. -5 +/- 2 mg/dl; P = 0.01). Serum CRP significantly decreased (1.31 +/- 0.6 vs. 0.33 +/- 0.1 mg/l; P = 0.02), alongside significant improvements in proteinuria (-0.15 +/- 0.03 vs. 0.02 +/- 0.01 g/day; P = 0.001) and urinary creatinine (-1.5 +/- 0.9 vs. 0.6 +/- 0.3 mg/dl; P = 0.01).
- Study type
- Longitudinal randomized clinical trial
- Who was studied
- 41 type 2 diabetic patients with nephropathy (18 men and 23 women)
- What was measured
- Cardiovascular risk factors, C-reactive protein (CRP), and kidney function indexes over 4 years
THE PAPER
Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial.
Azadbakht L, Atabak S, Esmaillzadeh A. Diabetes Care, 2008.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.